Balanced news tone
News Sentiment
GOVX sentiment intelligence
GeoVax Labs Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-17.4% over one week, -27.3% over four weeks, trend inactive, and below fair value.
GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
GeoVax Labs Inc (GOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates
GeoVax Labs Inc (GOVX) has an earnings forecast score of 7.33, ranking 295th in its industry. Analysts have set an average price target of $8.50, with a consensus "Buy" rating based on two analysts. The company's EPS for the last quarter was -$2.55, better than the market expecta
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 17 Jun 2026 20:09
- Source
- TradingKey
GeoVax Labs (GOVX) shareholders approve major warrant share issuances and governance items
GeoVax Labs shareholders have approved several key items at their recent annual meeting, including the election of seven directors, ratification of Wipfli LLP as the independent auditor for 2026, and advisory approval of executive compensation with future say-on-pay votes every t
- Tone
- Negative 32/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 20:09
- Source
- Stock Titan
GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 13:00
- Source
- NewMediaWire
GeoVax Labs Inc (GOVXW) Institutional Confidence
This article provides details on the institutional confidence for GeoVax Labs Inc (GOVXW), focusing on institutional shareholding and shareholder activity. It lists UBS Financial Services, Inc. and Clear Street LLC as notable shareholders with their respective shares held and per
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 09:40
- Source
- TradingKey
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 13:00
- Source
- NewMediaWire
GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 13:00
- Source
- NewMediaWire
GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 13:15
- Source
- NewMediaWire
How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Market source
GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Stock Titan
Why Is GeoVax Labs Stock Falling Tuesday?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Benzinga
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Market source
GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Quiver Quantitative
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 15 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
GeoVax Announces a Warrant Inducement Transaction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 14 Apr 2026 07:00
- Source
- Market source
Why The GeoVax Labs (GOVX) Story Is Shifting As Valuation Holds And Risks Rise
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Market source
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2026 08:00
- Source
- Market source
GeoVax Labs, Inc. (GOVX) Stock Price Quote Today & Current Price Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Nov 2025 06:11
- Source
- Capital.com
Geovax Labs (GOVXW) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:19
- Source
- Stock Titan
GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Sep 2024 07:00
- Source
- Market source
GeoVax Labs Inc USD0.001 share price | GOVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Dec 2020 11:38
- Source
- Hargreaves Lansdown